235.3. Septa| Link| Bookmark|
April 23, 2016 12:13:49 AM
(4000+ Posts, 4600+ Likes)
if you want to really value peers the ROE is most important it is same as what compound interest will do to ur money higher the rate better the return
A 10% rate take 7years plus to double and 20% takes 4 years to double.
same a higher return of equity
so now let compare these two the return in Dr lal is almost double which means this will also grow in double size if all other thing is same however here we find the EPS is all better in Dr lal so this will also have good effect on it future growth as it will start at a higher base.
presently Dr lal MC is approx 85 billion rupee and Thyrocare is approx 24 billion
if say the growth is half in Thyrocare compare to Dr lal my NAV would 42.5 billion less another 20% for less EPS meaning i can give it a MC of 34 Billion rupee and upside of 10 Billion which gives me a value of 632 rupee per share when the issue is offered at 446 an upside of at least Rs 185 premium of listing
This just based on RONW if i do a PE modelling the result will be more favourable price for THyrocare
a price of 748 is possible if u compare to Dr lal however that is not a fair value IMO
Hi, can anyone tell me what is ratio of allotment of thyrocare
228.1. Eagleye| Link| Bookmark|
April 22, 2016 1:40:42 PM
IPO Guru (6600+ Posts, 21900+ Likes)
The Share Registrar is waiting for applications to reach them first before deciding on ration of allotment ... unfortunately they are not smart enough to decide the ratio before that
Did anyone have any news on SEBI re introduction buy back condition on new IPO which is not got the nod from SEBI. In order to further protect RII given recent negative listing. Is this true or just a rumour
Improving compliance will negative for the primary market. I don''t understand why anyone need "Safety net" for negative listing. Do they not smart enough to research before investing.
:) I agree 100% with u in regards to safety net for negative listing. But rumour is that SEBI is planning to put in place I have mention earlier I am also against it and explained in long why it is not good idea with example of just dial IPO which was an IPO with safety net. I just want to know if this real or rumour
223. Eagleye| Link| Bookmark|
April 22, 2016 11:26:48 AM
IPO Guru (6600+ Posts, 21900+ Likes)
THYROCARE TECHNOLOGIES LIMITED
Issue is 100% Offer For Sale for 10,744,708 Equity Shares = Rs.479.21Crs (at Upper Price Band)
Issue Breakup A) QIB Portion 5,372,353 Equity Shares = Rs.239.60Crs Of which 1) Anchor Investor Portion 3,223,411 Equity Shares = 143.76Crs 2) QIBs other than Anchor Investors 2,148,942 Equity Shares = 95.84Crs
B) Non-Institutional Portion 1,611,707 Equity Shares = Rs.71.88Crs C) Retail Portion 3,760,648 Equity Shares = Rs.167.73Crs
Retail Portion 3,760,648 Equity Shares = 1,13,959 Forms (Market Lot being 33 Shares)
Equity Shares outstanding prior to the Offer and after the Offer 53,723,533 Equity Shares Thus, Post Issue the Market Cap will be Rs.2,396Crs (at Upper Price Band)